1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia – a propensity score analysis of data from a Japanese multicenter registry

BACKGROUND: Community-onset pneumonia (COP) is a combined concept of community acquired pneumonia and the previous classification of healthcare-associated pneumonia. Although ceftriaxone (CRO) is one of the treatment choices for COP, it is unclear whether 1 or 2 g CRO daily has better efficacy. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Shinya, Sada, Ryuichi, Yaegashi, Makito, Morimoto, Konosuke, Mori, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933656/
https://www.ncbi.nlm.nih.gov/pubmed/31878894
http://dx.doi.org/10.1186/s12879-019-4552-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933656/
https://www.ncbi.nlm.nih.gov/pubmed/31878894
http://dx.doi.org/10.1186/s12879-019-4552-8

Ejemplares similares